![]() Welcome to this issue of the MatTek Corp. In Vitro Newsletter. This newsletter summarizes recent significant events at MatTek and provides hyperlinks to more detailed information about these items on the MatTek Web site. You have received this email because, at some point, you expressed interest in MatTek In Vitro Products. If you do not wish to receive the MatTek In Vitro Newsletter, please use the link at the end of this email to unsubscribe. =========+=========+=========+=========+=========+=====
=========+=========+=========+=========+=========+===== EpiVaginal Receives U.S. Patent for HIV/AIDS ResearchEpiVaginal™, an innovative, human vaginal ectocervical cell-derived tissue model incorporating immune (dendritic) cells, for use by HIV/AIDS researchers in their investigations of HIV infection in women, has been granted a patent by the U.S. Patent Office.To read the entire press release, please click on the link below: EpiVaginal Receives U.S. Patent for HIV/AIDS Research =========+=========+=========+=========+=========+===== New - Melanoma Skin Tissue ModelTo enable a better understanding of the molecular and cellular mechanisms involved in the progression of cutaneous melanoma, MatTek has developed a full thickness melanoma skin model. To learn more about this exciting new tissue equivalent, please click on the link below:New Melanoma Skin Tissue Model =========+=========+=========+=========+=========+=====
|